Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $321.98 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $107.86 | 6 | $0 (2020) |
| GE Healthcare | $49.84 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $43.83 | 2 | $0 (2020) |
| Clovis Oncology, Inc. | $41.03 | 2 | $0 (2018) |
| Celgene Corporation | $33.21 | 2 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $19.37 | 1 | $0 (2017) |
| Biocompatibles, Inc. | $14.83 | 1 | $0 (2018) |
| Amgen Inc. | $12.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $37.46 | 2 | AstraZeneca Pharmaceuticals LP ($19.46) |
| 2019 | $42.84 | 2 | AstraZeneca Pharmaceuticals LP ($24.37) |
| 2018 | $102.63 | 6 | Clovis Oncology, Inc. ($41.03) |
| 2017 | $139.05 | 6 | GE Healthcare ($49.84) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/05/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 02/07/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.46 | General |
| 12/12/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Oncology | ||||||
| 06/14/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Oncology | ||||||
| 12/07/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Oncology | ||||||
| 08/22/2018 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 07/20/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Hematology / Oncology | ||||||
| 03/02/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Oncology | ||||||
| 02/13/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Oncology | ||||||
| 01/12/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Oncology | ||||||
| 12/16/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Oncology | ||||||
| 07/29/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Oncology | ||||||
| 06/22/2017 | GE Healthcare | — | Food and Beverage | Cash or cash equivalent | $49.84 | General |
| 05/19/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Hematology / Oncology | ||||||
| 04/21/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Immunology | ||||||
| 03/24/2017 | Amgen Inc. | Kyprolis (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 32 | 1,400 | 1,476 | $455,816 | $162,787 |
| 2021 | 32 | 1,582 | 1,702 | $439,007 | $148,579 |
| 2020 | 38 | 1,907 | 2,140 | $425,263 | $130,259 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 64 | 67 | $250,446 | $99,829 | 39.9% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 69 | 72 | $39,600 | $20,696 | 52.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 96 | 97 | $23,701 | $5,987 | 25.3% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Facility | 2022 | 92 | 105 | $21,851 | $5,707 | 26.1% |
| 70450 | Ct scan head or brain without contrast | Facility | 2022 | 131 | 136 | $17,787 | $4,354 | 24.5% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2022 | 45 | 46 | $12,127 | $3,154 | 26.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2022 | 40 | 41 | $11,303 | $3,073 | 27.2% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 311 | 353 | $10,166 | $2,530 | 24.9% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2022 | 49 | 49 | $8,281 | $1,866 | 22.5% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2022 | 22 | 22 | $6,517 | $1,617 | 24.8% |
| 70496 | Ct scan of blood vessels of head with contrast | Facility | 2022 | 17 | 17 | $4,597 | $1,205 | 26.2% |
| 70498 | Ct scan of blood vessels of neck with contrast | Facility | 2022 | 17 | 17 | $4,597 | $1,164 | 25.3% |
| 78195 | Nuclear medicine study of lymphatic system | Facility | 2022 | 24 | 24 | $4,390 | $1,149 | 26.2% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2022 | 35 | 35 | $4,576 | $1,142 | 24.9% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 28 | 28 | $4,449 | $1,132 | 25.4% |
| 70551 | Mri scan of brain without contrast | Facility | 2022 | 18 | 18 | $4,095 | $1,085 | 26.5% |
| 78580 | Nuclear medicine study of lung circulation | Facility | 2022 | 34 | 34 | $3,828 | $963.40 | 25.2% |
| 78227 | Nuclear medicine study of liver and bile duct system with use of drugs | Facility | 2022 | 23 | 23 | $2,980 | $813.05 | 27.3% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 15 | 16 | $3,069 | $729.80 | 23.8% |
| 78226 | Nuclear medicine study of liver and bile duct system | Facility | 2022 | 19 | 20 | $2,146 | $599.98 | 28.0% |
| 74210 | X-ray of voice box and/or esophagus with contrast | Facility | 2022 | 19 | 20 | $1,110 | $485.49 | 43.7% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 59 | 59 | $2,030 | $471.11 | 23.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2022 | 18 | 18 | $1,890 | $452.52 | 23.9% |
| 78315 | Nuclear medicine study of bone taken at different times | Facility | 2022 | 11 | 11 | $1,710 | $449.44 | 26.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2022 | 14 | 14 | $1,601 | $418.70 | 26.2% |
About Dr. Stephen Schmitter, M.D
Dr. Stephen Schmitter, M.D is a Body Imaging healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700963980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Schmitter, M.D has received a total of $321.98 in payments from pharmaceutical and medical device companies, with $37.46 received in 2020. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($321.98).
As a Medicare-enrolled provider, Schmitter has provided services to 4,889 Medicare beneficiaries, totaling 5,318 services with total Medicare billing of $441,624. Data is available for 3 years (2020–2022), covering 102 distinct procedure/service records.
Practice Information
- Specialty Body Imaging
- Other Specialties Nuclear Radiology, Diagnostic Radiology
- Location Dallas, TX
- Active Since 11/01/2006
- Last Updated 11/19/2024
- Taxonomy Code 2085B0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700963980
Products in Payments
- Xofigo (Drug) $89.86
- Rubraca (Drug) $41.03
- Revlimid (Drug) $33.21
- LYNPARZA (Drug) $24.37
- SOLIRIS (Drug) $19.37
- Stivarga (Drug) $18.00
- THERASPHERE - BIO (Device) $14.83
- Kyprolis (Biological) $12.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Body Imaging Doctors in Dallas
Dr. Joseph Philip, Md, MD
Body Imaging — Payments: $222.11
Dr. Bao Lan Pham, M.d, M.D
Body Imaging — Payments: $194.25
John Knight, Md, MD
Body Imaging — Payments: $145.72
Dr. Francisco Garcia-Morales, Md, MD
Body Imaging — Payments: $59.36
Dr. Mitchell Aboussie, Md, MD
Body Imaging
Vidisha Ghole
Body Imaging